FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054243044> ?p ?o ?g. }

• W2054243044 endingPage "648" @default.
• W2054243044 startingPage "638" @default.
• W2054243044 abstract "In the present study, we constructed a viable therapeutic vaccine of recombinant M. smegmatis mediated IL-12/GLS (granulysin) gene transfer into murine macrophages to exert the immunotherapy effects on the Mycobacterium tuberculosis infection. We tested this recombinant therapeutic vaccine in an in vivo study to determine its capability of stimulating host specific immune responses against M. tuberculosis. BALB/c mice intranasally immunized with the therapeutic vaccine developed an efficient Th1 protective immune response against M. tuberculosis which was equal to that of the BCG strain. Inoculation intranasally with this viable vaccine induced high level of serum IFN-gamma, IL-12 and IgG2a. The viable vaccine was capable of inducing purified protein derivative (PPD) antigen-specific splenocytes proliferation and IFN-gamma production from T cells in spleens of the immunized mice. In addition, intranasally inoculation with the viable vaccine can induce PPD antigen-specific sIgA production in the broncho-alveolar lavage fluid (BALF) of the immunized mice. No change of IL-4 level was found in all groups. The therapeutic mechanism of this viable vaccine against M. tuberculosis infection observed here appeared to be a result of the specific Th1 immune response activated by mycobacterium antigen from M. smegmatis and the expression of sIL-12/GLS in alveolar macrophages via the M. smegmatis-mediated gene transfer method. This research demonstrates that the therapeutic gene can be introduced into a host by viable mycobacteria works to induce the host specific immune response against M. tuberculosis infection in vivo. Since this therapeutic vaccine can strongly induce specific Th1 responses against M. tuberculosis in BALB/c mice and has no obviously harmfulness to the host simultaneously, the recombinant vaccine might be a potential candidate therapeutic vaccine against tuberculosis." @default.
• W2054243044 created "2016-06-24" @default.
• W2054243044 creator A5000485505 @default.
• W2054243044 creator A5000909501 @default.
• W2054243044 creator A5007730121 @default.
• W2054243044 creator A5015813083 @default.
• W2054243044 creator A5019002800 @default.
• W2054243044 creator A5022341004 @default.
• W2054243044 creator A5031315906 @default.
• W2054243044 creator A5054454797 @default.
• W2054243044 creator A5062171351 @default.
• W2054243044 creator A5069625270 @default.
• W2054243044 creator A5082556884 @default.
• W2054243044 creator A5084286876 @default.
• W2054243044 creator A5091188255 @default.
• W2054243044 creator A5091211722 @default.
• W2054243044 date "2007-01-01" @default.
• W2054243044 modified "2023-10-18" @default.
• W2054243044 title "Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice" @default.
• W2054243044 cites W1544076059 @default.
• W2054243044 cites W1582617014 @default.
• W2054243044 cites W1871506309 @default.
• W2054243044 cites W1934542416 @default.
• W2054243044 cites W1970279697 @default.
• W2054243044 cites W1979121196 @default.
• W2054243044 cites W1979955102 @default.
• W2054243044 cites W1982503163 @default.
• W2054243044 cites W2002986931 @default.
• W2054243044 cites W2012565980 @default.
• W2054243044 cites W2022561016 @default.
• W2054243044 cites W2032564220 @default.
• W2054243044 cites W2037222242 @default.
• W2054243044 cites W2040233064 @default.
• W2054243044 cites W2067116476 @default.
• W2054243044 cites W2074850685 @default.
• W2054243044 cites W2078538779 @default.
• W2054243044 cites W2089505771 @default.
• W2054243044 cites W2101855316 @default.
• W2054243044 cites W2117647978 @default.
• W2054243044 cites W2120297627 @default.
• W2054243044 cites W2124001620 @default.
• W2054243044 cites W2134582553 @default.
• W2054243044 cites W2135746704 @default.
• W2054243044 cites W2148209490 @default.
• W2054243044 cites W2151612737 @default.
• W2054243044 cites W2152562731 @default.
• W2054243044 cites W2154027290 @default.
• W2054243044 cites W2155858245 @default.
• W2054243044 cites W2156575228 @default.
• W2054243044 doi "https://doi.org/10.1016/j.vaccine.2006.08.037" @default.
• W2054243044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17000035" @default.
• W2054243044 hasPublicationYear "2007" @default.
• W2054243044 type Work @default.
• W2054243044 sameAs 2054243044 @default.
• W2054243044 citedByCount "23" @default.
• W2054243044 countsByYear W20542430442012 @default.
• W2054243044 countsByYear W20542430442013 @default.
• W2054243044 countsByYear W20542430442015 @default.
• W2054243044 countsByYear W20542430442016 @default.
• W2054243044 countsByYear W20542430442017 @default.
• W2054243044 countsByYear W20542430442023 @default.
• W2054243044 crossrefType "journal-article" @default.
• W2054243044 hasAuthorship W2054243044A5000485505 @default.
• W2054243044 hasAuthorship W2054243044A5000909501 @default.
• W2054243044 hasAuthorship W2054243044A5007730121 @default.
• W2054243044 hasAuthorship W2054243044A5015813083 @default.
• W2054243044 hasAuthorship W2054243044A5019002800 @default.
• W2054243044 hasAuthorship W2054243044A5022341004 @default.
• W2054243044 hasAuthorship W2054243044A5031315906 @default.
• W2054243044 hasAuthorship W2054243044A5054454797 @default.
• W2054243044 hasAuthorship W2054243044A5062171351 @default.
• W2054243044 hasAuthorship W2054243044A5069625270 @default.
• W2054243044 hasAuthorship W2054243044A5082556884 @default.
• W2054243044 hasAuthorship W2054243044A5084286876 @default.
• W2054243044 hasAuthorship W2054243044A5091188255 @default.
• W2054243044 hasAuthorship W2054243044A5091211722 @default.
• W2054243044 hasConcept C142724271 @default.
• W2054243044 hasConcept C147483822 @default.
• W2054243044 hasConcept C159047783 @default.
• W2054243044 hasConcept C203014093 @default.
• W2054243044 hasConcept C2777204207 @default.
• W2054243044 hasConcept C2777975735 @default.
• W2054243044 hasConcept C2779078216 @default.
• W2054243044 hasConcept C2779341262 @default.
• W2054243044 hasConcept C2781069245 @default.
• W2054243044 hasConcept C71924100 @default.
• W2054243044 hasConcept C85663871 @default.
• W2054243044 hasConcept C86803240 @default.
• W2054243044 hasConcept C8891405 @default.
• W2054243044 hasConcept C89423630 @default.
• W2054243044 hasConceptScore W2054243044C142724271 @default.
• W2054243044 hasConceptScore W2054243044C147483822 @default.
• W2054243044 hasConceptScore W2054243044C159047783 @default.
• W2054243044 hasConceptScore W2054243044C203014093 @default.
• W2054243044 hasConceptScore W2054243044C2777204207 @default.
• W2054243044 hasConceptScore W2054243044C2777975735 @default.
• W2054243044 hasConceptScore W2054243044C2779078216 @default.
• W2054243044 hasConceptScore W2054243044C2779341262 @default.

• next